<DOC>
	<DOC>NCT03066570</DOC>
	<brief_summary>Objective: To investigate the effects of a cognitive behavioural intervention targeting specific fears in patients with painful diabetic neuropathy, on physical activity and quality of life.</brief_summary>
	<brief_title>Graded Exposure in Patients With Painful Diabetic Neuropathy</brief_title>
	<detailed_description>Intervention: Graded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity. Main study parameters/endpoints: The purpose of this project is to develop and test a cognitive behavioural intervention targeting specific fears in patients with PDN, in order to increase physical activity and improve QOL.</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Patients with type II diabetes mellitus, aged &gt; 18 years who suffer from peripheral polyneuropathy. Patients with lower limb morbidities other than PDN such as peripheral arterial disease severe osteoarthritis, any other neurological disease than PDN or any other disease that may cause pain in the feet and/or damage to the peripheral nervous system (e.g. ulcers).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Graded Exposure</keyword>
	<keyword>Quality of Life</keyword>
	<keyword>Physical Activity</keyword>
	<keyword>Anxiety</keyword>
</DOC>